While there is currently no cure for fatty liver disease (FLD) or nonalcoholic steatohepatitis (NASH), a condition to which FLD can lead, the pharmaceutical industry is turning to clinical research […]
The U.S. Food and Drug Administration (FDA) is taking a look in the mirror as the new year gets under way, and is liking most of what it sees. Working […]
ACRP Executive Director Jim Kremidas discusses the important role workforce diversity can play in clinical trial participation in this December 30 segment with NPR's Marketplace.
Next year promises “a rough road .for some sites” when it comes to budgeting and designing financial workflows to sustain operations, says Dr. Kelly Willenberg, DBA, RN, CCRP, CHC, CHRC, […]
Two Phase III clinical trials have begun evaluating investigational monoclonal antibodies for their safety and efficacy in treating people hospitalized with moderate COVID-19. The trials are part of the ACTIV-3 […]